<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:57:54Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4528928" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4528928</identifier><datestamp>2015-08-24</datestamp><setSpec>actaf2</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Crystallogr F Struct Biol Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Acta Crystallogr F Struct Biol Commun</journal-id>
      <journal-id journal-id-type="publisher-id">Acta Cryst. F</journal-id>
      <journal-title-group>
        <journal-title>Acta Crystallographica. Section F, Structural Biology Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2053-230X</issn>
      <publisher>
        <publisher-name>International Union of Crystallography</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4528928</article-id>
      <article-id pub-id-type="pmcid">PMC4528928</article-id>
      <article-id pub-id-type="pmc-uid">4528928</article-id>
      <article-id pub-id-type="pmid">26249686</article-id>
      <article-id pub-id-type="publisher-id">hv5298</article-id>
      <article-id pub-id-type="doi">10.1107/S2053230X15010183</article-id>
      <article-id pub-id-type="coden">ACSFEN</article-id>
      <article-id pub-id-type="publisher-id">S2053230X15010183</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Communications</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure of the human MLH1 N-terminus: implications for predisposition to Lynch syndrome</article-title>
        <alt-title>Human MLH1 N-terminus</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lam</surname>
            <given-names>Robert</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tempel</surname>
            <given-names>Wolfram</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kerr</surname>
            <given-names>Iain D.</given-names>
          </name>
          <xref ref-type="aff" rid="b">b</xref>
          <xref ref-type="corresp" rid="cor">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Min</surname>
            <given-names>Jinrong</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
          <xref ref-type="aff" rid="c">c</xref>
          <xref ref-type="corresp" rid="cor">*</xref>
        </contrib>
        <aff id="a"><label>a</label>Structural Genomics Consortium, <institution>University of Toronto</institution>, 101 College Street, Toronto, ON M5G 1L7, <country>Canada</country></aff>
        <aff id="b"><label>b</label><institution>Myriad Genetic Laboratories Inc.</institution>, 320 Wakara Way, Salt Lake City, UT 84108, <country>USA</country></aff>
        <aff id="c"><label>c</label>Department of Physiology, <institution>University of Toronto</institution>, Toronto, ON M5G 1L7, <country>Canada</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor">Correspondence e-mail: <email>ikerr@myriad.com</email>, <email>jr.min@utoronto.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <day>1</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>71</volume>
      <issue>Pt 8</issue>
      <issue-id pub-id-type="publisher-id">f150800</issue-id>
      <fpage>981</fpage>
      <lpage>985</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Wu et al. 2015</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/uk/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1107/S2053230X15010183">A full version of this article is available from Crystallography Journals Online.</self-uri>
      <abstract abstract-type="toc">
        <p>The crystal structure of the human MLH1 N-terminus is reported at 2.30âÃ resolution. The overall structure is described along with an analysis of two clinically important mutations.</p>
      </abstract>
      <abstract>
        <p>Mismatch repair prevents the accumulation of erroneous insertions/deletions and non-WatsonâCrick base pairs in the genome. Pathogenic mutations in the <italic>MLH1</italic> gene are associated with a predisposition to Lynch and Turcotâs syndromes. Although genetic testing for these mutations is available, robust classification of variants requires strong clinical and functional support. Here, the first structure of the N-terminus of human MLH1, determined by X-ray crystallography, is described. The structure shares a high degree of similarity with previously determined prokaryotic <italic>MLH1</italic> homologs; however, this structure affords a more accurate platform for the classification of <italic>MLH1</italic> variants.</p>
      </abstract>
      <kwd-group>
        <kwd>ATPase</kwd>
        <kwd>GHKL</kwd>
        <kwd>Lynch syndrome</kwd>
        <kwd>mismatch repair</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <label>1.</label>
      <title>Introduction Â  </title>
      <p>Pathogenic mutations in the DNA mismatch-repair gene <italic>MLH1</italic> (MutL homolog 1) are associated with a predisposition to Lynch syndrome (Bronner <italic>et al.</italic>, 1994<xref ref-type="bibr" rid="bb9"> â¸</xref>; Papadopoulos <italic>et al.</italic>, 1994<xref ref-type="bibr" rid="bb45"> â¸</xref>), a hereditary cancer syndrome that accounts for 2â4% of all colorectal cancer cases in the US (Aaltonen <italic>et al.</italic>, 1998<xref ref-type="bibr" rid="bb1"> â¸</xref>; Hampel <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb21"> â¸</xref>, 2008<xref ref-type="bibr" rid="bb20"> â¸</xref>; Lynch &amp; de la Chapelle, 2003<xref ref-type="bibr" rid="bb36"> â¸</xref>). Mismatch repair (MMR) is a complex, multicomponent process that is coordinated by a number of distinct DNA-repair factors. <italic>MLH1</italic> homologs are conserved across all domains of life and are essential components of MMR (Lin <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb34"> â¸</xref>). Human MLH1 (hMLH1) is a 756-amino-acid, 84âkDa protein that can be roughly divided into two halves: an N-terminal domain (NTD), where the ATPase activity resides, and a C-terminal domain (CTD), which is the site of dimerization with MLH1 paralogs (Guerrette <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb19"> â¸</xref>). In higher eukaryotes, the MLH1 and PMS2 (postmeotic segregation increased 2) paralogs form a heterodimeric complex, MutLÎ±. Once a lesion has been identified and isolated by the MutS mismatch-recognition complex, MutLÎ± is recruited (Fukui, 2010<xref ref-type="bibr" rid="bb18"> â¸</xref>; MartÃ­n-LÃ³pez &amp; Fishel, 2013<xref ref-type="bibr" rid="bb37"> â¸</xref>) and, <italic>via</italic> its C-terminal endonuclease activity (Kadyrov <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb29"> â¸</xref>), generates nicks in the heteroduplex 3â² and 5â² to the mismatch that facilitate excision and replicative repair (Kadyrov <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb29"> â¸</xref>, 2007<xref ref-type="bibr" rid="bb30"> â¸</xref>; Modrich, 2006<xref ref-type="bibr" rid="bb40"> â¸</xref>). While other roles for MutLÎ± have been proposed, these are less well understood (Her <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb22"> â¸</xref>; Liu <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb35"> â¸</xref>; McVety <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb38"> â¸</xref>; Pedrazzi <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb46"> â¸</xref>; Yanamadala &amp; Ljungman, 2003<xref ref-type="bibr" rid="bb67"> â¸</xref>). Whilst the exact details remain unclear, the ability of MLH1 to interact with adenine nucleotides is an important factor in MMR, inducing large conformational changes in the protein (Sacho <italic>et al.</italic>, 2008<xref ref-type="bibr" rid="bb50"> â¸</xref>). Mutations that impair ATP binding or hydrolysis have a severe effect on <italic>in vitro</italic> MMR activity (Tomer <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb58"> â¸</xref>; Johnson <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb26"> â¸</xref>). In addition, ATP binding is required for the interaction of MutLÎ± with MutSÎ±, with MLH1 predominantly being responsible for this interaction (Plotz <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb47"> â¸</xref>).</p>
      <p>In this report, we present the X-ray crystal structure of a ternary MgâADP complex of the human MLH1 NTD domain determined to 2.30âÃ resolution, which is the first report of a human MLH1 structure. As missense variants that disrupt the structure and/or function of this domain have the potential to cause disease, our structure helps to provide a direct mechanistic explanation to support the functional effect of <italic>MLH1</italic> variants identified in patients who receive clinical genetic testing.</p>
    </sec>
    <sec id="sec2">
      <label>2.</label>
      <title>Materials and methods Â  </title>
      <sec id="sec2.1">
        <label>2.1.</label>
        <title>Protein expression and purification Â  </title>
        <p>The sequence encoding the N-terminal domain of hMLH1 (residues 1â340) was amplified by PCR and subcloned into the pET-28-MHL vector (GenBank deposition ID EF456735) downstream of the polyhistidine affinity tag. The protein was overexpressed in <italic>Escherichia coli</italic> BL21 (DE3) V2R-pRARE cells in Terrific Broth medium in the presence of 50âÂµgâml<sup>â1</sup> kanamycin. The cells were grown at 37Â°C to an OD<sub>600ânm</sub> of 1.5, induced by the addition of 1âm<italic>M</italic> isopropyl Î²-<sc>d</sc>-1-thioÂ­galactopyranoside (IPTG) and incubated overnight at 15Â°C. The cells were harvested by centrifugation at 7000ârevâmin<sup>â1</sup> and resuspended in 50âm<italic>M</italic> HEPES pH 7.4, 500âm<italic>M</italic> NaCl, 2âm<italic>M</italic> Î²-mercaptoethanol, 5% glycerol, 0.1% CHAPS, 1âm<italic>M</italic> phenylmethylsulfonyl fluoride (PMSF). The cells were lysed by passage through a microfluidizer (Microfluidics Corporation) at 138âMPa. After clarification of the crude extract by high-speed centrifugation, the lysate was applied onto a 5âml HiTrap Chelating column (GE Healthcare) charged with Ni<sup>2+</sup>. The column was washed with ten column volumes of 20âm<italic>M</italic> HEPES pH 7.4 containing 500âm<italic>M</italic> NaCl, 50âm<italic>M</italic> imidazole and 5% glycerol. The protein was eluted in 20âm<italic>M</italic> HEPES pH 7.4, 500âm<italic>M</italic> NaCl, 250âm<italic>M</italic> imidazole, 5% glycerol and then loaded onto a Superdex 200 (26/60, GE Healthcare) column equilibrated in 20âm<italic>M</italic> PIPES pH 6.5 buffer containing 250âm<italic>M</italic> NaCl. TEV protease was added to the combined fractions containing MLH1. The protein was further purified to homogeneity by ion-exchange chromatography on a Source 30S column (10/10; GE Healthcare) and eluted in a final buffer consisting of 20âm<italic>M</italic> PIPES pH 6.5, 250âm<italic>M</italic> NaCl.</p>
      </sec>
      <sec id="sec2.2">
        <label>2.2.</label>
        <title>Crystallization and structure determination Â  </title>
        <p>Purified MLH1 protein (10âmgâml<sup>â1</sup>) was mixed with ADP at a 1:5 molar ratio of protein:ligand and crystallized using the sitting-drop vapor-diffusion method by mixing 1âÂµl protein solution with 1âÂµl reservoir solution consisting of 20% PEG 4000, 10% 2-propanol, 0.1â<italic>M</italic> HEPES pH 7.5.</p>
        <p>Diffraction data were collected on beamline 19ID at the Advanced Photon Source, Argonne National Laboratory. Reflection intensities from 150 1Â° diffraction images were initially integrated and scaled using <italic>HKL</italic>-3000 (Minor <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb39"> â¸</xref>). Using the crystal structure of <italic>E. coli</italic> MutL (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1b62">1b62</ext-link>; 36% amino-acid sequence identity; Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>; Johnson <italic>et al.</italic>, 2008<xref ref-type="bibr" rid="bb27"> â¸</xref>) as the search model, the structure was solved by molecular replacement with <italic>MOLREP</italic> (Vagin &amp; Teplyakov, 2010<xref ref-type="bibr" rid="bb59"> â¸</xref>). The initial refinement alternated cycles of restrained refinement including TLS parameterization in <italic>REFMAC</italic> (Murshudov <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb41"> â¸</xref>; Winn <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb66"> â¸</xref>) with interactive rebuilding in <italic>Coot</italic> (Emsley <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb16"> â¸</xref>). After renewed processing of the same diffraction images with <italic>XDS</italic> (Kabsch, 2010<xref ref-type="bibr" rid="bb28"> â¸</xref>) and additional scaling with <italic>AIMLESS</italic> (Evans &amp; Murshudov, 2013<xref ref-type="bibr" rid="bb17"> â¸</xref>), the model was further refined using <italic>autoBUSTER</italic> (Blanc <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb7"> â¸</xref>; Bricogne <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb8"> â¸</xref>) and <italic>REFMAC</italic> interspersed with interactive rebuilding.</p>
        <p>The <italic>MolProbity</italic> statistics of the model compared favorably with a set of reference structures with similar data resolution (<italic>MolProbity</italic> server v.4.1-537). The model was deposited in the PDB using the <italic>PDB_EXTRACT</italic> tool (Yang <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb68"> â¸</xref>) with accession code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=4p7a">4p7a</ext-link>. Data-collection, model-refinement and validation statistics are summarized in Table 1<xref ref-type="table" rid="table1"> â¸</xref>. All figures were prepared using <italic>PyMOL</italic> (v.1.5.0.4; SchrÃ¶dinger).</p>
      </sec>
    </sec>
    <sec id="sec3">
      <label>3.</label>
      <title>Results and discussion Â  </title>
      <sec id="sec3.1">
        <label>3.1.</label>
        <title>Overall structure Â  </title>
        <p>Crystals of the hMLH1 NTD formed in space group <italic>P</italic>6<sub>4</sub> with one molecule in the asymmetric unit. The crystallized hMLH1 construct contained residues 1â340 of the full-length protein. The crystallographic model included amino-acid residues 3â85, 98â299 and 320â336. Atoms with little or no electron density were deemed to be disordered and were omitted from the final model. Also included were ADP, an Mg<sup>2+</sup> ion, 35 water molecules and nine sites with electron densities that we failed to confidently interpret in terms of specific chemical features. These sites are designated âUNXâ in the coordinate file (unknown atoms or ions). A <italic>DALI</italic> search (Holm &amp; RosenstrÃ¶m, 2010<xref ref-type="bibr" rid="bb24"> â¸</xref>) identified the <italic>E. coli</italic> MutL NTD (LN40; Ban &amp; Yang, 1998<xref ref-type="bibr" rid="bb5"> â¸</xref>) as the closest structural homolog (Fig. 1<xref ref-type="fig" rid="fig1"> â¸</xref>). Superimposition of our structure with the <italic>E. coli</italic> MutLâMgâADP ternary complex (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1b62">1b62</ext-link>) using <italic>CEAlign</italic> (Jia <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb25"> â¸</xref>; Shindyalov &amp; Bourne, 1998<xref ref-type="bibr" rid="bb54"> â¸</xref>) matches 288 C<sup>Î±</sup> positions with a root-mean-square deviation (r.m.s.d.) of 2.5âÃ. Given the similarity to <italic>E. coli</italic> MutL NTD and to be consistent with the nomenclature established by Ban &amp; Yang (1998<xref ref-type="bibr" rid="bb5"> â¸</xref>), we designate our structure human LN40 (hLN40).</p>
        <p>The overall structure of hLN40 can be divided into two subdomains (Fig. 1<xref ref-type="fig" rid="fig1"> â¸</xref>), an ATPase domain and a âtransducerâ domain, connected by a two-helix linker. The ATPase domain (residues 25â207) contains the noncanonical, ATPase Bergerat fold, the core of which is composed of a four-stranded, antiparallel Î²-sheet (Î²1âÎ²3 and Î²5) and three Î±-helices (Î±BâÎ±D) (Bergerat <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb6"> â¸</xref>). The fold is essentially identical to the topology observed in <italic>E. coli</italic> LN40 and identifies MLH1 as a member of the GHKL (<bold>g</bold>yrase, <bold>H</bold>sp90, histidine <bold>k</bold>inase, Mut<bold>L</bold>) ATPase/kinase superfamily of proteins (Dutta &amp; Inouye, 2000<xref ref-type="bibr" rid="bb15"> â¸</xref>). The ATP-binding loop between helices Î±C and Î±D (residues 74â85 and 98â101) defines the pyrophosphate binding site and is variable in structure and length across the family (Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>; Prodromou <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb48"> â¸</xref>; Steussy <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb56"> â¸</xref>; Wigley <italic>et al.</italic>, 1991<xref ref-type="bibr" rid="bb64"> â¸</xref>). In addition to the similarity observed in the overall structure between hLN40 and the MutL structure (Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>), we also observed the presence of an hLN40 crystallographic dimer similar to that observed in the <italic>E. coli</italic> MutLâMgâADP complex. However, in contrast to the prokaryotic structure, the hLN40 ATP-binding loop is partially disordered, possibly owing to crystal packing. Accordingly, residues 86â97 have been omitted from our model owing to a lack of interpretable electron density. The C-terminus of the ATP-binding loop is part of a conserved GFRGE(A/G)L motif (residues 98â104) that is found in related mismatch-repair proteins (Sehgal &amp; Singh, 2012<xref ref-type="bibr" rid="bb53"> â¸</xref>) and is an extension of motif III (the âG2 boxâ) conserved in GHKL family members (Mushegian <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb43"> â¸</xref>). Gly98 and Gly101 are positioned adjacent to the pyrophosÂ­phate moiety of the bound ADP, permitting the close approach of ADP to the N-terminus of helix Î±D. This allows the negatively charged ligand to take advantage of a half positive unit charge that arises from the helix dipole moment (Hol <italic>et al.</italic>, 1978<xref ref-type="bibr" rid="bb23"> â¸</xref>; Wierenga <italic>et al.</italic>, 1985<xref ref-type="bibr" rid="bb63"> â¸</xref>). The presence of a glycine-rich motif is consistent with a conserved mechanism that has evolved to play a crucial role in the active site of several nucleotide-binding folds (Saraste <italic>et al.</italic>, 1990<xref ref-type="bibr" rid="bb51"> â¸</xref>; Walker <italic>et al.</italic>, 1982<xref ref-type="bibr" rid="bb61"> â¸</xref>; Wierenga <italic>et al.</italic>, 1985<xref ref-type="bibr" rid="bb63"> â¸</xref>).</p>
        <p>Residues 228â336 fold separately to form a small Î±/Î² barrel at the hLN40 C-terminus, known as the transducer domain (Classen <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb11"> â¸</xref>). This domain is characterized by a ribosomal protein S5 domain 2-like fold (Murzin <italic>et al.</italic>, 1995<xref ref-type="bibr" rid="bb42"> â¸</xref>) and a left-handed Î±-helical crossover (Î±I) between Î²10 and Î²11 (Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>; Cole &amp; Bystroff, 2009<xref ref-type="bibr" rid="bb12"> â¸</xref>; Richardson, 1976<xref ref-type="bibr" rid="bb49"> â¸</xref>). A large body of evidence points towards the allosteric regulation of the transducer domain playing a central role in coordinating the downstream functions of GHKLs (Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>; Corbett &amp; Berger, 2003<xref ref-type="bibr" rid="bb13"> â¸</xref>, 2005<xref ref-type="bibr" rid="bb14"> â¸</xref>; Lamour <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb33"> â¸</xref>; Oestergaard <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb44"> â¸</xref>; Wei <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb62"> â¸</xref>; Wigley <italic>et al.</italic>, 1991<xref ref-type="bibr" rid="bb64"> â¸</xref>). In particular, the âQTKâ loop (hLN40 residues 298â320) has been proposed to act as an ATP âsensorâ that helps to couple changes in ligand binding and hydrolysis to rigid-body movements and conformational changes in the transducer domain (Wei <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb62"> â¸</xref>). Residues 301â320 in the hLN40 QTK loop are disordered; however, we can infer from MutL structures (Ban <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb4"> â¸</xref>) that Lys311 within the PTK motif should act as the conserved basic, Î³-phosphate-sensing residue. Crystallographic studies by both Corbett &amp; Berger (2005<xref ref-type="bibr" rid="bb14"> â¸</xref>) and Stanger <italic>et al.</italic> (2014<xref ref-type="bibr" rid="bb55"> â¸</xref>) highlight the importance of rigid-body motions between the ATPase and transducer domains of GHKLs. In particular, these studies identified several distinct conformational intermediates that exist along the ATP-hydrolysis pathway. However, without further structural and biochemical information on catalytically competent forms of hLN40, it remains to be seen whether these observations represent a unifying mechanism that explains how GHKLs achieve their higher-order functions in the cell.</p>
      </sec>
      <sec id="sec3.2">
        <label>3.2.</label>
        <title>Structural basis for the pathogenicity of <italic>MLH1</italic> mutations Â  </title>
        <p>Structural and functional information may be utilized to determine the pathogenicity of <italic>MLH1</italic> mutations identified during genetic testing for hereditary cancer syndromes. Here, we present two such pathogenic variants, c.83C&gt;T (p.Pro28Leu) and c.464T&gt;G (p.Leu155Arg) (Thompson <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb57"> â¸</xref>). Pro28 is a buried residue at the N-terminus of Î±A in the ATPase domain and is completely inaccessible to the solvent (Krissinel &amp; Henrick, 2007<xref ref-type="bibr" rid="bb32"> â¸</xref>). The introduction of a Leu at this tightly packed position in p.Pro28Leu is likely to introduce severe steric clashes, given its more extended side chain. Sterically, the most favorable rotamer still shows increased van der Waals (vdW) strain and steric clashes involving Gly54, Gly55, Ile59 and Ile176 that are likely to disrupt the core fold of the protein (Fig. 2<xref ref-type="fig" rid="fig2"> â¸</xref>
<italic>a</italic>).</p>
        <p>Leu155 is also buried in the Î±/Î² sandwich of the ATPase domain, between helix Î±B and the extended Î²-sheet (Fig. 2<xref ref-type="fig" rid="fig2"> â¸</xref>
<italic>b</italic>). Substitution by Arg at this position could have two consequences. Firstly, outside an active site or stabilizing secondary-structure element, the introduction of an unbalanced, buried charge is often considered to be destabilizing to protein structure (Kajander <italic>et al.</italic>, 2000<xref ref-type="bibr" rid="bb31"> â¸</xref>; Waldburger <italic>et al.</italic>, 1995<xref ref-type="bibr" rid="bb60"> â¸</xref>; Wimley <italic>et al.</italic>, 1996<xref ref-type="bibr" rid="bb65"> â¸</xref>). Incorporating the most favorable rotamer, the modeled Arg at position 155 is surrounded by a cluster of nonpolar residues (Ala31, Ile25, Ile107 and Val152) and is unable to form hydrogen bonds to nearby side-chain or main-chain atoms. The second structural consequence of p.Leu155Arg relates to the compact space in the center of the Î±/Î² sandwich, which imposes a steric constraint on the type of amino acid that can be accommodated at position 155. Compared with Leu, the more extended alkyl-guanidinium side chain of Arg introduces severe steric clashes, which disrupt the architecture of the elements (for example helix Î±D) that form the active site of the enzyme.</p>
        <p>Given this structural rationale, we expect the MLH1 structure reported here to be of great clinical utility in the analysis of missense variants found in patients recommended for genetic testing. The structure provides a robust platform, in combination with other strong functional or clinical evidence, to help to determine the clinical effect of loss-of-function mutations. We caution, however, against reliance on this model to predict a benign effect in a clinical setting, as truly pathogenic variants may fall within the ânormalâ functional range. Therefore, other factors must be considered when a seemingly benign substitution is encountered, including the possibility that a nonsynonymous change may have an effect on mRNA splicing or post-translational modification of the protein.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data">
        <p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="4p7a">human MLH1 N-terminus, 4p7a</ext-link>
</p>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We acknowledge the efforts of the clinicians and patients who have participated in Myriad Genetics Laboratoriesâ Variant Classification Program. We thank Krystal Brown for her assistance with manuscript editing and submission. We also thank Dr John R. Walker for providing helpful comments during the refinement of the MLH1 model. We thank Peter Loppnau, Chas Bountra, Cheryl Arrowsmith and Aled Edwards for their contributions to defining the crystal structure of hLN40. Some results shown in this report are derived from work performed at Argonne National Laboratory Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago Argonne LLC for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bb1">
        <mixed-citation publication-type="other">Aaltonen, L. A. <italic>et al.</italic> (1998). <italic>N. Engl. J. Med.</italic>
<bold>338</bold>, 1481â1487.</mixed-citation>
      </ref>
      <ref id="bb2">
        <mixed-citation publication-type="other">Adams, P. D. <italic>et al.</italic> (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 213â221.</mixed-citation>
      </ref>
      <ref id="bb3">
        <mixed-citation publication-type="other">Afonine, P. V., Grosse-Kunstleve, R. W., Chen, V. B., Headd, J. J., Moriarty, N. W., Richardson, J. S., Richardson, D. C., Urzhumtsev, A., Zwart, P. H. &amp; Adams, P. D. (2010). <italic>J. Appl. Cryst.</italic>
<bold>43</bold>, 669â676.</mixed-citation>
      </ref>
      <ref id="bb4">
        <mixed-citation publication-type="other">Ban, C., Junop, M. &amp; Yang, W. (1999). <italic>Cell</italic>, <bold>97</bold>, 85â97.</mixed-citation>
      </ref>
      <ref id="bb5">
        <mixed-citation publication-type="other">Ban, C. &amp; Yang, W. (1998). <italic>Cell</italic>, <bold>95</bold>, 541â552.</mixed-citation>
      </ref>
      <ref id="bb6">
        <mixed-citation publication-type="other">Bergerat, A., de Massy, B., Gadelle, D., Varoutas, P. C., Nicolas, A. &amp; Forterre, P. (1997). <italic>Nature (London)</italic>, <bold>386</bold>, 414â417.</mixed-citation>
      </ref>
      <ref id="bb7">
        <mixed-citation publication-type="other">Blanc, E., Roversi, P., Vonrhein, C., Flensburg, C., Lea, S. M. &amp; Bricogne, G. (2004). <italic>Acta Cryst.</italic> D<bold>60</bold>, 2210â2221.</mixed-citation>
      </ref>
      <ref id="bb8">
        <mixed-citation publication-type="other">Bricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W., Roversi, P., Sharff, A., Smart, O., Vonrhein, C. &amp; Womack, T. (2011). <italic>BUSTER</italic> v.2.11.2. Cambridge: Global Phasing Ltd.</mixed-citation>
      </ref>
      <ref id="bb9">
        <mixed-citation publication-type="other">Bronner, C. E. <italic>et al.</italic> (1994). <italic>Nature (London)</italic>, <bold>368</bold>, 258â261.</mixed-citation>
      </ref>
      <ref id="bb10">
        <mixed-citation publication-type="other">Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. &amp; Richardson, D. C. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 12â21.</mixed-citation>
      </ref>
      <ref id="bb11">
        <mixed-citation publication-type="other">Classen, S., Olland, S. &amp; Berger, J. M. (2003). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>100</bold>, 10629â10634.</mixed-citation>
      </ref>
      <ref id="bb12">
        <mixed-citation publication-type="other">Cole, B. J. &amp; Bystroff, C. (2009). <italic>Protein Sci.</italic>
<bold>18</bold>, 1602â1608.</mixed-citation>
      </ref>
      <ref id="bb13">
        <mixed-citation publication-type="other">Corbett, K. D. &amp; Berger, J. M. (2003). <italic>EMBO J.</italic>
<bold>22</bold>, 151â163.</mixed-citation>
      </ref>
      <ref id="bb14">
        <mixed-citation publication-type="other">Corbett, K. D. &amp; Berger, J. M. (2005). <italic>Structure</italic>, <bold>13</bold>, 873â882.</mixed-citation>
      </ref>
      <ref id="bb15">
        <mixed-citation publication-type="other">Dutta, R. &amp; Inouye, M. (2000). <italic>Trends Biochem. Sci.</italic>
<bold>25</bold>, 24â28.</mixed-citation>
      </ref>
      <ref id="bb16">
        <mixed-citation publication-type="other">Emsley, P., Lohkamp, B., Scott, W. G. &amp; Cowtan, K. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 486â501.</mixed-citation>
      </ref>
      <ref id="bb17">
        <mixed-citation publication-type="other">Evans, P. R. &amp; Murshudov, G. N. (2013). <italic>Acta Cryst.</italic> D<bold>69</bold>, 1204â1214.</mixed-citation>
      </ref>
      <ref id="bb18">
        <mixed-citation publication-type="other">Fukui, K. (2010). <italic>J. Nucleic Acids</italic>, <bold>2010</bold>, 260512.</mixed-citation>
      </ref>
      <ref id="bb19">
        <mixed-citation publication-type="other">Guerrette, S., Acharya, S. &amp; Fishel, R. (1999). <italic>J. Biol. Chem.</italic>
<bold>274</bold>, 6336â6341.</mixed-citation>
      </ref>
      <ref id="bb20">
        <mixed-citation publication-type="other">Hampel, H. <italic>et al.</italic> (2008). <italic>J. Clin. Oncol.</italic>
<bold>26</bold>, 5783â5788.</mixed-citation>
      </ref>
      <ref id="bb21">
        <mixed-citation publication-type="other">Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., Panescu, J., Fix, D., Lockman, J., Comeras, I. &amp; de la Chapelle, A. (2005). <italic>N. Engl. J. Med.</italic>
<bold>352</bold>, 1851â1860.</mixed-citation>
      </ref>
      <ref id="bb22">
        <mixed-citation publication-type="other">Her, C., Vo, A. T. &amp; Wu, X. (2002). <italic>DNA Repair (Amst.)</italic>, <bold>1</bold>, 719â729.</mixed-citation>
      </ref>
      <ref id="bb23">
        <mixed-citation publication-type="other">Hol, W. G., van Duijnen, P. T. &amp; Berendsen, H. J. (1978). <italic>Nature (London)</italic>, <bold>273</bold>, 443â446.</mixed-citation>
      </ref>
      <ref id="bb24">
        <mixed-citation publication-type="other">Holm, L. &amp; RosenstrÃ¶m, P. (2010). <italic>Nucleic Acids Res.</italic>
<bold>38</bold>, W545âW549.</mixed-citation>
      </ref>
      <ref id="bb25">
        <mixed-citation publication-type="other">Jia, Y., Dewey, T. G., Shindyalov, I. N. &amp; Bourne, P. E. (2004). <italic>J. Comput. Biol.</italic>
<bold>11</bold>, 787â799.</mixed-citation>
      </ref>
      <ref id="bb26">
        <mixed-citation publication-type="other">Johnson, J. R., Erdeniz, N., Nguyen, M., Dudley, S. &amp; Liskay, R. M. (2010). <italic>DNA Repair (Amst.)</italic>, <bold>9</bold>, 1209â1213.</mixed-citation>
      </ref>
      <ref id="bb27">
        <mixed-citation publication-type="other">Johnson, M., Zaretskaya, I., Raytselis, Y., Merezhuk, Y., McGinnis, S. &amp; Madden, T. L. (2008). <italic>Nucleic Acids Res.</italic>
<bold>36</bold>, W5âW9.</mixed-citation>
      </ref>
      <ref id="bb28">
        <mixed-citation publication-type="other">Kabsch, W. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 125â132.</mixed-citation>
      </ref>
      <ref id="bb29">
        <mixed-citation publication-type="other">Kadyrov, F. A., Dzantiev, L., Constantin, N. &amp; Modrich, P. (2006). <italic>Cell</italic>, <bold>126</bold>, 297â308.</mixed-citation>
      </ref>
      <ref id="bb30">
        <mixed-citation publication-type="other">Kadyrov, F. A., Holmes, S. F., Arana, M. E., Lukianova, O. A., OâDonnell, M., Kunkel, T. A. &amp; Modrich, P. (2007). <italic>J. Biol. Chem.</italic>
<bold>282</bold>, 37181â37190.</mixed-citation>
      </ref>
      <ref id="bb31">
        <mixed-citation publication-type="other">Kajander, T., Kahn, P. C., Passila, S. H., Cohen, D. C., LehtiÃ¶, L., Adolfsen, W., Warwicker, J., Schell, U. &amp; Goldman, A. (2000). <italic>Structure</italic>, <bold>8</bold>, 1203â1214.</mixed-citation>
      </ref>
      <ref id="bb32">
        <mixed-citation publication-type="other">Krissinel, E. &amp; Henrick, K. (2007). <italic>J. Mol. Biol.</italic>
<bold>372</bold>, 774â797.</mixed-citation>
      </ref>
      <ref id="bb33">
        <mixed-citation publication-type="other">Lamour, V., Hoermann, L., Jeltsch, J. M., Oudet, P. &amp; Moras, D. (2002). <italic>J. Biol. Chem.</italic>
<bold>277</bold>, 18947â18953.</mixed-citation>
      </ref>
      <ref id="bb34">
        <mixed-citation publication-type="other">Lin, Z., Nei, M. &amp; Ma, H. (2007). <italic>Nucleic Acids Res.</italic>
<bold>35</bold>, 7591â7603.</mixed-citation>
      </ref>
      <ref id="bb35">
        <mixed-citation publication-type="other">Liu, Y., Fang, Y., Shao, H., Lindsey-Boltz, L., Sancar, A. &amp; Modrich, P. (2010). <italic>J. Biol. Chem.</italic>
<bold>285</bold>, 5974â5982.</mixed-citation>
      </ref>
      <ref id="bb36">
        <mixed-citation publication-type="other">Lynch, H. T. &amp; de la Chapelle, A. (2003). <italic>N. Engl. J. Med.</italic>
<bold>348</bold>, 919â932.</mixed-citation>
      </ref>
      <ref id="bb37">
        <mixed-citation publication-type="other">MartÃ­n-LÃ³pez, J. V. &amp; Fishel, R. (2013). <italic>Fam. Cancer</italic>, <bold>12</bold>, 159â168.</mixed-citation>
      </ref>
      <ref id="bb38">
        <mixed-citation publication-type="other">McVety, S., Younan, R., Li, L., Gordon, P. H., Wong, N., Foulkes, W. D. &amp; Chong, G. (2005). <italic>Clin. Genet.</italic>
<bold>68</bold>, 234â238.</mixed-citation>
      </ref>
      <ref id="bb39">
        <mixed-citation publication-type="other">Minor, W., Cymborowski, M., Otwinowski, Z. &amp; Chruszcz, M. (2006). <italic>Acta Cryst.</italic> D<bold>62</bold>, 859â866.</mixed-citation>
      </ref>
      <ref id="bb40">
        <mixed-citation publication-type="other">Modrich, P. (2006). <italic>J. Biol. Chem.</italic>
<bold>281</bold>, 30305â30309.</mixed-citation>
      </ref>
      <ref id="bb41">
        <mixed-citation publication-type="other">Murshudov, G. N., SkubÃ¡k, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. &amp; Vagin, A. A. (2011). <italic>Acta Cryst.</italic> D<bold>67</bold>, 355â367.</mixed-citation>
      </ref>
      <ref id="bb42">
        <mixed-citation publication-type="other">Murzin, A. G., Brenner, S. E., Hubbard, T. &amp; Chothia, C. (1995). <italic>J. Mol. Biol.</italic>
<bold>247</bold>, 536â540.</mixed-citation>
      </ref>
      <ref id="bb43">
        <mixed-citation publication-type="other">Mushegian, A. R., Bassett, D. E. Jr, Boguski, M. S., Bork, P. &amp; Koonin, E. V. (1997). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>94</bold>, 5831â5836.</mixed-citation>
      </ref>
      <ref id="bb44">
        <mixed-citation publication-type="other">Oestergaard, V. H., Bjergbaek, L., Skouboe, C., Giangiacomo, L., Knudsen, B. R. &amp; Andersen, A. H. (2004). <italic>J. Biol. Chem.</italic>
<bold>279</bold>, 1684â1691.</mixed-citation>
      </ref>
      <ref id="bb45">
        <mixed-citation publication-type="other">Papadopoulos, N. <italic>et al.</italic> (1994). <italic>Science</italic>, <bold>263</bold>, 1625â1629.</mixed-citation>
      </ref>
      <ref id="bb46">
        <mixed-citation publication-type="other">Pedrazzi, G., Perrera, C., Blaser, H., Kuster, P., Marra, G., Davies, S. L., Ryu, G.-H., Freire, R., Hickson, I. D., Jiricny, J. &amp; Stagljar, I. (2001). <italic>Nucleic Acids Res.</italic>
<bold>29</bold>, 4378â4386.</mixed-citation>
      </ref>
      <ref id="bb47">
        <mixed-citation publication-type="other">Plotz, G., Raedle, J., Brieger, A., Trojan, J. &amp; Zeuzem, S. (2003). <italic>Nucleic Acids Res.</italic>
<bold>31</bold>, 3217â3226.</mixed-citation>
      </ref>
      <ref id="bb48">
        <mixed-citation publication-type="other">Prodromou, C., Roe, S. M., Piper, P. W. &amp; Pearl, L. H. (1997). <italic>Nature Struct. Mol. Biol.</italic>
<bold>4</bold>, 477â482.</mixed-citation>
      </ref>
      <ref id="bb49">
        <mixed-citation publication-type="other">Richardson, J. S. (1976). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>73</bold>, 2619â2623.</mixed-citation>
      </ref>
      <ref id="bb50">
        <mixed-citation publication-type="other">Sacho, E. J., Kadyrov, F. A., Modrich, P., Kunkel, T. A. &amp; Erie, D. A. (2008). <italic>Mol. Cell</italic>, <bold>29</bold>, 112â121.</mixed-citation>
      </ref>
      <ref id="bb51">
        <mixed-citation publication-type="other">Saraste, M., Sibbald, P. R. &amp; Wittinghofer, A. (1990). <italic>Trends Biochem. Sci.</italic>
<bold>15</bold>, 430â434.</mixed-citation>
      </ref>
      <ref id="bb53">
        <mixed-citation publication-type="other">Sehgal, M. &amp; Singh, T. R. (2012). <italic>J. Nat. Sci. Biol. Med.</italic>
<bold>3</bold>, 139â146.</mixed-citation>
      </ref>
      <ref id="bb54">
        <mixed-citation publication-type="other">Shindyalov, I. N. &amp; Bourne, P. E. (1998). <italic>Protein Eng. Des. Sel.</italic>
<bold>11</bold>, 739â747.</mixed-citation>
      </ref>
      <ref id="bb55">
        <mixed-citation publication-type="other">Stanger, F. V., Dehio, C. &amp; Schirmer, T. (2014). <italic>PLoS One</italic>, <bold>9</bold>, e107289.</mixed-citation>
      </ref>
      <ref id="bb56">
        <mixed-citation publication-type="other">Steussy, C. N., Popov, K. M., Bowker-Kinley, M. M., Sloan, R. B. Jr, Harris, R. A. &amp; Hamilton, J. A. (2001). <italic>J. Biol. Chem.</italic>
<bold>276</bold>, 37443â37450.</mixed-citation>
      </ref>
      <ref id="bb57">
        <mixed-citation publication-type="other">Thompson, B. A. <italic>et al.</italic> (2014). <italic>Nature Genet.</italic>
<bold>46</bold>, 107â115.</mixed-citation>
      </ref>
      <ref id="bb58">
        <mixed-citation publication-type="other">Tomer, G., Buermeyer, A. B., Nguyen, M. M. &amp; Liskay, R. M. (2002). <italic>J. Biol. Chem.</italic>
<bold>277</bold>, 21801â21809.</mixed-citation>
      </ref>
      <ref id="bb59">
        <mixed-citation publication-type="other">Vagin, A. &amp; Teplyakov, A. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 22â25.</mixed-citation>
      </ref>
      <ref id="bb60">
        <mixed-citation publication-type="other">Waldburger, C. D., Schildbach, J. F. &amp; Sauer, R. T. (1995). <italic>Nature Struct. Mol. Biol.</italic>
<bold>2</bold>, 122â128.</mixed-citation>
      </ref>
      <ref id="bb61">
        <mixed-citation publication-type="other">Walker, J. E., Saraste, M., Runswick, M. J. &amp; Gay, N. J. (1982). <italic>EMBO J.</italic>
<bold>1</bold>, 945â951.</mixed-citation>
      </ref>
      <ref id="bb62">
        <mixed-citation publication-type="other">Wei, H., Ruthenburg, A. J., Bechis, S. K. &amp; Verdine, G. L. (2005). <italic>J. Biol. Chem.</italic>
<bold>280</bold>, 37041â37047.</mixed-citation>
      </ref>
      <ref id="bb63">
        <mixed-citation publication-type="other">Wierenga, R. K., De Maeyer, M. C. H. &amp; Hol, W. G. J. (1985). <italic>Biochemistry</italic>, <bold>24</bold>, 1346â1357.</mixed-citation>
      </ref>
      <ref id="bb64">
        <mixed-citation publication-type="other">Wigley, D. B., Davies, G. J., Dodson, E. J., Maxwell, A. &amp; Dodson, G. (1991). <italic>Nature (London)</italic>, <bold>351</bold>, 624â629.</mixed-citation>
      </ref>
      <ref id="bb65">
        <mixed-citation publication-type="other">Wimley, W. C., Gawrisch, K., Creamer, T. P. &amp; White, S. H. (1996). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>93</bold>, 2985â2990.</mixed-citation>
      </ref>
      <ref id="bb66">
        <mixed-citation publication-type="other">Winn, M. D., Isupov, M. N. &amp; Murshudov, G. N. (2001). <italic>Acta Cryst.</italic> D<bold>57</bold>, 122â133.</mixed-citation>
      </ref>
      <ref id="bb67">
        <mixed-citation publication-type="other">Yanamadala, S. &amp; Ljungman, M. (2003). <italic>Mol. Cancer Res.</italic>
<bold>1</bold>, 747â754.</mixed-citation>
      </ref>
      <ref id="bb68">
        <mixed-citation publication-type="other">Yang, H., Guranovic, V., Dutta, S., Feng, Z., Berman, H. M. &amp; Westbrook, J. D. (2004). <italic>Acta Cryst.</italic> D<bold>60</bold>, 1833â1839.</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Superimposition of hLN40 and <italic>E. coli</italic> LN40 (PDB entry <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1b62">1b62</ext-link>). hLN40 is colored yellow, while the <italic>E. coli</italic> homolog is colored green. The ATPase and transducer domains are located to the right and left, respectively, of the short loop colored blue. Residues in the ATP-binding loop of hLN40 are colored magenta, while those in <italic>E. coli</italic> LN40 are colored pink (the loop in the latter is ordered owing to extensive crystal contacts). In hLN40, ADP is depicted in stick representation and Mg<sup>2+</sup> is shown as a green sphere. Secondary-structure elements are labelled beginning at the N-Â­terminus, with the first helix being Î±A and the first Î²-strand being Î²1.</p>
      </caption>
      <graphic xlink:href="f-71-00981-fig1"/>
    </fig>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Structural basis for the pathogenicity of <italic>MLH1</italic> missense variants. Ribbon diagrams showing the structural consequences of (<italic>a</italic>) c.83C&gt;T (p.Pro28Leu) and (<italic>b</italic>) c.464T&gt;G (p.Leu155Arg). The figure is colored as in Fig. 1<xref ref-type="fig" rid="fig1"> â¸</xref>, with the exception that structural elements outside the core Bergerat fold are colored cyan. Important amino acids around the mutation are represented as sticks. The mutation is colored grey. Red circles represent steric clashes with surrounding parts of the structure. For clarity, the transducer domain is omitted from both figures.</p>
      </caption>
      <graphic xlink:href="f-71-00981-fig2"/>
    </fig>
    <table-wrap id="table1" position="float">
      <label>Table 1</label>
      <caption>
        <title>Data-collection, refinement and validation statistics for the hLN40 structure</title>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody valign="top">
          <tr>
            <td rowspan="1" colspan="2" align="left" valign="top">Data collection/reduction</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Radiation source</td>
            <td rowspan="1" colspan="1" align="left" valign="top">19ID, APS</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Wavelength ()</td>
            <td rowspan="1" colspan="1" align="left" valign="top">0.9793</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Space group</td>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>P</italic>6<sub>4</sub>
</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Unit-cell parameters (, )</td>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>a</italic> = <italic>b</italic> = 94.57, <italic>c</italic> = 85.82, = = 90.00, = 120.00</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Resolution limits ()</td>
            <td rowspan="1" colspan="1" align="left" valign="top">47.282.30 (2.382.30)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Unique reflections</td>
            <td rowspan="1" colspan="1" align="left" valign="top">19468 (1888)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Completeness (%)</td>
            <td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>merge</sub>
</td>
            <td rowspan="1" colspan="1" align="left" valign="top">0.059 (1.11)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>meas</sub>
</td>
            <td rowspan="1" colspan="1" align="left" valign="top">0.062 (1.18)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Mean <italic>I</italic>/(<italic>I</italic>)</td>
            <td rowspan="1" colspan="1" align="left" valign="top">27.1 (2.3)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Multiplicity</td>
            <td rowspan="1" colspan="1" align="left" valign="top">9.5 (9.5)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" align="left" valign="top">Model refinement</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Resolution ()</td>
            <td rowspan="1" colspan="1" align="left" valign="top">40.002.30</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Reflections used/in test set</td>
            <td rowspan="1" colspan="1" align="left" valign="top">18456/981</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" align="left" valign="top">No. of atoms</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Total</td>
            <td rowspan="1" colspan="1" align="left" valign="top">2296</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Protein</td>
            <td rowspan="1" colspan="1" align="left" valign="top">2222</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Water</td>
            <td rowspan="1" colspan="1" align="left" valign="top">37</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Others</td>
            <td rowspan="1" colspan="1" align="left" valign="top">37</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" align="left" valign="top">Average <italic>B</italic> factor (<sup>2</sup>)</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Overall</td>
            <td rowspan="1" colspan="1" align="left" valign="top">65.9</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Protein</td>
            <td rowspan="1" colspan="1" align="left" valign="top">66.7</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Water</td>
            <td rowspan="1" colspan="1" align="left" valign="top">45.9</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Others</td>
            <td rowspan="1" colspan="1" align="left" valign="top">39.9</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Wilson <italic>B</italic> factor<xref ref-type="table-fn" rid="tfn1">â </xref> (<sup>2</sup>)</td>
            <td rowspan="1" colspan="1" align="left" valign="top">51.4</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>R</italic>
<sub>work</sub>/<italic>R</italic>
<sub>free</sub>
</td>
            <td rowspan="1" colspan="1" align="left" valign="top">0.203/0.254</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">R.m.s.d., bonds ()/angles ()</td>
            <td rowspan="1" colspan="1" align="left" valign="top">0.014/1.4</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" align="left" valign="top">Model validation<xref ref-type="table-fn" rid="tfn2">â¡</xref>
</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Ramachandran plot</td>
            <td rowspan="1" colspan="1">Â </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Favored (%)</td>
            <td rowspan="1" colspan="1" align="left" valign="top">98.33</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Outliers (%)</td>
            <td rowspan="1" colspan="1" align="left" valign="top"> 0.00</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">Clashscore</td>
            <td rowspan="1" colspan="1" align="left" valign="top">1.82</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" align="left" valign="top">
<italic>MolProbity</italic> score</td>
            <td rowspan="1" colspan="1" align="left" valign="top">1.15</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1">
          <label>â </label>
          <p>Obtained using <italic>phenix.model_vs_data</italic> (Afonine <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb3"> â¸</xref>).</p>
        </fn>
        <fn id="tfn2">
          <label>â¡</label>
          <p>Obtained using <italic>phenix.molprobity</italic> (Adams <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb2"> â¸</xref>; Chen <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb10"> â¸</xref>).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>